Combined Lidocaine and Depot Corticosteroid Knee Injection
Patients should be offered local anesthetic (lidocaine) mixed with depot corticosteroid for intra-articular knee injections, with strict aseptic technique, using 40 mg triamcinolone or methylprednisolone mixed with 2-4 mL of lidocaine (10 mg/mL), limited to 3-4 injections per year with at least 3-month intervals. 1
Dosage and Preparation
For the corticosteroid component:
- Use 40 mg triamcinolone or methylprednisolone acetate (1 mL of 40 mg/mL concentration)
- Evidence shows 40 mg is as effective as 80 mg for knee injections 2
- Higher doses provide no additional benefit and increase adverse event risk
For the lidocaine component:
- Mix with 2-4 mL of lidocaine hydrochloride (10 mg/mL) 3, 4
- Warming the lidocaine to 37°C reduces injection pain 1
- The lidocaine serves dual purposes: immediate procedural pain relief and extending overall pain reduction
Injection Technique
Accuracy and guidance:
- Ultrasound guidance increases injection accuracy and reduces procedural pain 1, 2
- Consider ultrasound particularly for difficult anatomy or when landmark-based approaches have failed
- Patient should be positioned on an examination table, able to lie flat 1
Aseptic technique is mandatory: 1
- Use surgical gloves
- Prepare skin with alcohol, iodine, or chlorhexidine
- Perform in a clean, well-lit, private room with resuscitation equipment nearby 1
- The infection risk is approximately 0.035% (3 per 7,900 procedures) with proper technique 1
Frequency and Timing
Injection intervals:
- Limit to 3-4 injections per year maximum in the same joint 1
- Allow at least 3 months between injections 1
- Recent evidence shows dose-dependent risk: patients receiving 3+ injections have higher rates of progression to total knee arthroplasty 5
Timing considerations:
- Perform at least 3 months before any planned joint replacement surgery 1
- Injections within 3 months of surgery increase infection risk from 0.5% to 1.0% 1
- After joint replacement, only perform following consultation with the surgical team 1
Safety Precautions
Diabetic patients require specific counseling: 1
- Inform about transient hyperglycemia risk (days 1-3 post-injection)
- Advise glucose monitoring, especially in suboptimally controlled diabetes
- Blood glucose typically peaks during the first 3 days post-injection
Anticoagulation is NOT a contraindication:
- Proceed unless bleeding risk is high 1
- Do not routinely hold antithrombotic medications
Prosthetic joints:
- Avoid routine injections in prosthetic joints 1
- If necessary, only after strict screening for prosthetic infection by orthopedic surgery
- Infection rate is 0.6% in prosthetic knees (1 in 625 injections) 1
Post-Injection Care
Activity modification: 1
- Avoid overuse of the injected joint for 24 hours
- Do NOT immobilize the joint—immobilization provides no benefit
- Normal activity is appropriate after the first 24 hours
- Bed rest, splinting, or bandages add no value 1
Expected Outcomes and Shared Decision-Making
Efficacy timeline:
- Short-term pain relief typically lasts weeks to a few months 2
- One study showed mean improvement of 9.4 points on KOOS scale over 12 weeks with corticosteroid versus -1.3 with lidocaine alone 4
- 47% of patients achieved clinically meaningful improvement (≥16 points) 4
Re-injection decisions should consider: 1
- Response to previous injections
- Other available treatment options
- Systemic treatments and comorbidities
- Individual patient factors and preferences
Critical Pitfalls to Avoid
- Never inject without confirming diagnosis—rule out infection or other contraindications first 1
- Do not exceed 3-4 injections per year—evidence suggests dose-dependent harm with repeated injections 5
- Do not inject within 3 months of planned surgery—doubles infection risk 1
- Do not use higher doses thinking they work better—40 mg is as effective as 80 mg 2
- Do not forget to counsel diabetic patients—hyperglycemia is predictable and requires monitoring 1